81P Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial
Titel:
81P Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial
Auteur:
Fayette, J. Bauman, J. Salas, S. Colevas, D. Even, C. Cupissol, D. Posner, M.R. Lefebvre, G. Saada-Bouzid, E. Bernadach, M. Seiwert, T. Pearson, A. Messouak, S. Cornen, S.L. Andre, P. Rotolo, F. Boyer-Chammard, A. Cohen, R.B.